IMAGO BIOSCIENCES INC's ticker is and the CUSIP is 45250K107. A total of 106 filers reported holding IMAGO BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $8,464,140 | – | 235,442 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,018,737 | $58,171,000 | 11.90% |
Frazier Life Sciences Management, L.P. | 2,971,274 | $57,256,000 | 4.88% |
Parkman Healthcare Partners LLC | 139,751 | $2,693,000 | 0.79% |
StepStone Group LP | 522,987 | $10,078,000 | 0.75% |
AlpInvest Partners B.V. | 90,469 | $1,743,000 | 0.56% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 260,118 | $5,012,000 | 0.52% |
EMERALD ADVISERS, LLC | 616,368 | $11,877,000 | 0.45% |
EMERALD MUTUAL FUND ADVISERS TRUST | 506,358 | $9,758,000 | 0.43% |
Woodline Partners LP | 831,830 | $16,029,000 | 0.26% |
FARALLON CAPITAL MANAGEMENT LLC | 2,471,313 | $47,622,000 | 0.23% |